Hemagglutinin H5 (Influenza A virus) (H5 HA)

Hemagglutinin H5 is a major surface glycoprotein of the Influenza A virus, particularly associated with highly pathogenic avian influenza (HPAI) strains such as H5N1. It plays a dual role in the viral life cycle: the globular head domain mediates attachment to host cell sialic acid receptors, while the conserved stalk region facilitates the fusion of the viral envelope with the host endosomal membrane (UniProt, Sino Biological). This fusion process is triggered by the acidic environment of the endosome, which induces a dramatic conformational change in the protein (PubMed). As the primary antigen on the viral surface, H5 is the central target for neutralizing antibodies and the development of seasonal and pandemic vaccines (NIH, PMC). Therapeutic interventions targeting H5 include monoclonal antibodies like MEDI8852 and VIS-410, which block receptor binding or stabilize the stalk to prevent fusion, as well as small-molecule inhibitors like umifenovir (PubMed, Journal of Virology). However, the high mutation rate of the virus, known as antigenic drift, poses a significant challenge to long-term efficacy, necessitating continuous surveillance and the development of universal vaccines targeting conserved epitopes (Wikipedia, PMC). Due to its potential for zoonotic transmission and high mortality rates in humans, Hemagglutinin H5 remains a critical focus for global biosecurity and antiviral research (CDC, WHO).

Other names

H5 hemagglutininHA5H5 proteinInfluenza A virus H5 proteinHemagglutinin H5 subtypeH5 surface glycoprotein

Inhibition of viral entry by blocking the receptor binding site on the globular head or stabilizing the stalk region to prevent pH-dependent membrane fusion.